Back
Neurocrine Biosciences Stock Predictions
Buy
60
NBIX
Neurocrine Biosciences
Last Price:
142.31
Seasonality Move:
6.24%
7 Day Trial
ALL ACCESS PASS
$
7
Neurocrine Biosciences Stock Forecast
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 29.9% based on the past 27 years of stock performance.
- Neurocrine Biosciences has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
-
Is Neurocrine Biosciences Stock Undervalued?
The current Neurocrine Biosciences [NBIX] share price is $142.29. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences Stock Go Up Next Year?
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 29.9% based on the past 27 years of stock performance.
Neurocrine Biosciences Stock Rating
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences overpriced?
- Neurocrine Biosciences has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
Neurocrine Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
148.37
52-Week Low:
89.04
Prediction Charts
Market Cap:
14.32B
Price in USD:
142.29
Volume:
639.92K
Beta:
0.78
Technical Analysis
SMA50:
138.59
SMA100:
136.90
SMA200:
124.43
52-Wk Change:
49.35%
Stock Predictions
-
Is Neurocrine Biosciences stock public?
Yes, Neurocrine Biosciences is a publicly traded company. -
What is the Neurocrine Biosciences stock quote today?
The Neurocrine Biosciences stock price is 142.29 USD today. -
How to buy Neurocrine Biosciences stock online?
You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 138.07 | 137.48 | 140.47 | 137.34 |
May-1 | 140.18 | 143.18 | 145.22 | 136.01 |
May-2 | 143.79 | 139.73 | 144.09 | 139.63 |
May-3 | 140.90 | 140.71 | 141.88 | 139.23 |
May-6 | 140.55 | 141.71 | 143.57 | 140.55 |
May-7 | 142.03 | 143.13 | 143.86 | 140.90 |
May-8 | 143.50 | 139.02 | 143.54 | 138.15 |
May-9 | 139.36 | 139.57 | 140.71 | 138.95 |
May-10 | 140.00 | 136.70 | 141.00 | 136.10 |
May-13 | 138.00 | 136.15 | 138.69 | 135.23 |
May-14 | 137.12 | 138.48 | 138.73 | 134.79 |
May-15 | 138.90 | 142.00 | 142.19 | 138.90 |
May-16 | 141.17 | 141.91 | 142.30 | 140.17 |
May-17 | 141.97 | 142.29 | 142.86 | 140.51 |
Neurocrine Biosciences Earnings
Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences Forecast Revenue Growth
Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.04 per share, an increase this year of $1.88 per share, and an increase next year of $1.37 per share.
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.